Applied Therapeutics Ownership | Who Owns Applied Therapeutics?


OverviewForecastRevenueFinancialsChart

Applied Therapeutics Ownership Summary


Applied Therapeutics is owned by 757.19% institutional investors, 5.70% insiders. Vestal point capital, lp is the largest institutional shareholder, holding 79.67% of APLT shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.15% of its assets in Applied Therapeutics shares.

APLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockApplied Therapeutics757.19%5.70%-662.89%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vestal point capital, lp11.50M79.67%$9.85M
Vr adviser9.99M69.21%$8.55M
Propel bio management9.62M66.61%$8.23M
Blackrock funding, inc. /de9.30M64.40%$7.96M
Schonfeld strategic advisors8.76M60.70%$7.50M
Vanguard group5.55M38.44%$4.75M
T. rowe price investment management5.42M37.56%$4.64M
Deutsche bank ag\4.47M30.95%$3.84M
Simplify asset management2.82M19.52%$2.41M
Alyeska investment group2.71M18.76%$2.32M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management5.57M17.54%$26.03M
Propel bio management9.62M8.18%$8.23M
Stempoint capital lp2.21M3.03%$10.33M
Vr adviser9.99M0.59%$8.55M
Vestal point capital, lp11.50M0.58%$9.85M
Windsor advisory group416.76K0.41%$356.83K
Tang capital management2.43M0.14%$2.08M
Artal group1.01M0.12%$4.71M
Simplify asset management2.82M0.12%$2.41M
Rock springs capital management lp1.92M0.06%$1.64M

Top Buyers

HolderShares% AssetsChange
Vestal point capital, lp11.50M0.58%10.36M
Schonfeld strategic advisors8.76M0.04%8.42M
Blackrock6.57M0.00%5.58M
T. rowe price investment management5.42M0.00%5.21M
Propel bio management9.62M8.18%3.05M

Top Sellers

HolderShares% AssetsChange
Janus henderson group35.79K--10.51M
Perceptive advisors860.00K0.02%-7.14M
Franklin resources2.00M0.00%-4.80M
Frazier life sciences management---2.29M
Adage capital partners gp1.96M0.00%-2.15M

New Positions

HolderShares% AssetsChangeValue
Jefferies financial group276.70K0.00%276.70K$236.91K
Norges bank243.20K-243.20K$208.23K
Hrt financial lp242.88K0.00%242.88K$207.00K
Aristides capital156.51K0.03%156.51K$134.00K
Swiss national bank146.90K0.00%146.90K$125.78K

Sold Out

HolderChange
National bank of canada /fi/-4.00
True wealth design-72.00
Lindbrook capital-103.00
Newedge advisors-199.00
Accent capital management-602.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024127-11.19%109,297,179-3.04%7570.12%79-8.14%26-18.75%
Sep 30, 202414341.58%112,721,8809.20%78011.51%8537.10%3337.50%
Jun 30, 20241011.00%103,226,9789.86%821.47%62-7.46%2450.00%
Mar 31, 202410012.36%93,965,70353.04%741.41%6715.52%1645.45%
Dec 31, 20238956.14%61,400,84742.94%723.25%5870.59%1157.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Simplify Propel Opportunities ETF3.67M3.15%850.00K
T. Rowe Price Small-Cap Value3.38M2.91%3.00M
Vanguard Total Stock Mkt Idx Inv3.10M2.67%-
iShares Russell 2000 ETF2.51M2.16%-49.08K
T. Rowe Price U.S. SC Value Eq Tr-Z1.88M1.62%1.81M
SPDR® S&P Biotech ETF1.74M1.49%24.74K
Janus Henderson Global Life Sciences D1.62M1.39%1.30M
Janus Henderson Glb Life Scn I2 USD1.29M1.11%1.29M
Franklin Biotechnology Discv A(acc)USD1.26M1.09%-
Vanguard Institutional Extnd Mkt Idx Tr1.26M1.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2025Perfetti Riccardo Chief Medical OfficerSell$4.56K
Mar 04, 2025Funtleyder Leslie D. See RemarksSell$6.38K
Mar 04, 2025Chinoporos Constantine See RemarksSell$196.68
Feb 06, 2025Funtleyder Leslie D. See RemarksSell$14.00K
Feb 06, 2025Perfetti Riccardo Chief Medical OfficerSell$52.51K

Insider Transactions Trends


DateBuySell
2025 Q1-6
2024 Q4--
2024 Q3-5
2024 Q2-5
2024 Q1-4

APLT Ownership FAQ


Who Owns Applied Therapeutics?

Applied Therapeutics shareholders are primarily institutional investors at 757.19%, followed by 5.70% insiders and -662.89% retail investors. The average institutional ownership in Applied Therapeutics's industry, Biotech Stocks , is 69.02%, which Applied Therapeutics exceeds.

Who owns the most shares of Applied Therapeutics?

Applied Therapeutics’s largest shareholders are Vestal point capital, lp (11.5M shares, 79.67%), Vr adviser (9.99M shares, 69.21%), and Propel bio management (9.62M shares, 66.61%). Together, they hold 215.50% of Applied Therapeutics’s total shares outstanding.

Does Blackrock own Applied Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Applied Therapeutics.

Who is Applied Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Applied Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.54% of its assets in 5.57M Applied Therapeutics shares, valued at 26.03M$.

Who is the top mutual fund holder of Applied Therapeutics shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Applied Therapeutics shares, with 3.15% of its total shares outstanding invested in 3.67M Applied Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools